Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Interferon-alpha

  • Open Access
    Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
    MINNA KANKURI-TAMMILEHTO, LAURA PERASTO, SEPPO PYRHONEN and EEVA SALMINEN
    Anticancer Research June 2023, 43 (6) 2645-2657; DOI: https://doi.org/10.21873/anticanres.16431
  • You have access
    Role of Interferon-alpha in Patients with Neuroendocrine Tumors: A Retrospective Study
    EITAN MIRVIS, DALVINDER MANDAIR, JORGE GARCIA-HERNANDEZ, MULLAN MOHMADUVESH, CHRISTOS TOUMPANAKIS and MARTYN CAPLIN
    Anticancer Research November 2014, 34 (11) 6601-6607;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire